Oxford Biomedica (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Oxford Biomedica" in English language version.

refsWebsite

Global rank English rank

2pharmatimes.com

low place

low place

low place

low place

1web.archive.org

1^st place

1^st place

1ftserussell.com

low place

low place

6,507^th place

4,996^th place

1books.google.com

3^rd place

3^rd place

210^th place

157^th place

low place

low place

low place

low place

1thepharmaletter.com

low place

low place

1fancycomma.com

low place

low place

1fiercepharma.com

low place

8,921^st place

1thebusinessmagazine.co.uk

low place

low place

books.google.com

Owen, Geoffrey; Hopkins, Michael M. (2016). Science, the State and the City: Britain's Struggle to Succeed in Biotechnology. Oxford University Press. p. 174. ISBN 978-0198728009.

evaluate.com

"Plenty of choice remains for buyers of gene therapy". Evaluate.com. 20 December 2019. Retrieved 26 March 2020.

fancycomma.com

"Could the Oxford University/AstraZeneca COVID-19 Vaccine End the Pandemic?". 2 July 2020. Retrieved 25 June 2020.

fiercepharma.com

"Oxford Biomedica earns U.K. nod for 4th manufacturing suite to boost COVID-19 production". Fierce Pharma. 6 October 2020. Retrieved 8 May 2021.

ft.com

Cookson, Clive (6 June 2018). "Oxford Biomedica seals $842m Parkinson's therapy deal with Axovant". Retrieved 27 June 2018.

ftserussell.com

research.ftserussell.com

"FTSE UK Index Series: Annual Review June 2020". 3 June 2020. Archived from the original on 3 June 2020. Retrieved 3 June 2020.

hoovers.com

Hoover's | A D&B Company. Hoovers.com.

investis.com

otp.investis.com

"Annual Results 2023". Oxford Biomedica. Retrieved 29 April 2024.

labiotech.eu

Smith, Jonathan (29 May 2019). "€60M Investment to Boost Oxford Biomedica's Gene and Cell Therapies". Labiotech.eu. Retrieved 13 March 2020.

pharmatimes.com

Rut, Andrew (28 October 2019). "Transforming the landscape". PharmaTimes. Retrieved 4 March 2020.
"Oxford Biomedica joins consortium for promising COVID-19 vaccine". Pharma Times. 8 April 2020. Retrieved 3 June 2020.

thebusinessmagazine.co.uk

"Oxford Biomedica acquires ABL Europe". The Business Magazine. 28 September 2023. Retrieved 28 September 2023.

thepharmaletter.com

"Oxford Biomedica extends lentiviral deal with Swiss giant". Phara Letter. 19 December 2019. Retrieved 3 June 2020.

web.archive.org

"FTSE UK Index Series: Annual Review June 2020". 3 June 2020. Archived from the original on 3 June 2020. Retrieved 3 June 2020.